BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 3876433)

  • 1. Enhancement of Clq binding activity by IgM rheumatoid factor.
    Zilberfarb JL; Andrews BS; Young AC; Davis JS
    J Rheumatol; 1985 Jun; 12(3):444-8. PubMed ID: 3876433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating immune complexes and rheumatoid arthritis.
    Faaber P; Rijke Schilder TP; Capel PJ; Koene RA
    J Rheumatol; 1985 Oct; 12(5):849-53. PubMed ID: 3878875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and partial characterization of immune complexes in patients with rheumatoid arthritis plus Sjogren's syndrome and with Sjogren's syndrome alone.
    Yoshinoya S; McDuffy S; Alarcon-Segovia D; Pope RM
    Clin Exp Immunol; 1982 May; 48(2):339-47. PubMed ID: 6980743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of rheumatoid factor--its complement activating property and isotype].
    Masuda M; Ota T; Suzuki H; Eto S
    Ryumachi; 1992 Aug; 32(4):283-91. PubMed ID: 1411790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of six tests for circulating IgG complexes with special reference to IgM rheumatoid factors: analysis of systemic lupus erythematosus and rheumatoid arthritis series.
    Wager O; Lindström P; Räsänen JA; Kekomäki R; Ziola B; Salmi A; Isomäki H; Skrifvars B; Penttinen K
    Clin Exp Immunol; 1981 Oct; 46(1):149-60. PubMed ID: 7337967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative studies in patients with seropositive and seronegative chronic polyarthritis using the solid-phase ELISA test for the determination of rheumatoid factors of classes IgM, IgG and IgA].
    Zlabinger GJ; Bröll H
    Z Rheumatol; 1988; 47(2):107-12. PubMed ID: 3388991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The roles of IgG, IgM rheumatoid factor, and their complexes in the induction of polymorphonuclear leukocyte chemotactic factor from complement.
    Wagner T; Abraham G; Baum J
    J Clin Invest; 1974 Jun; 53(6):1503-11. PubMed ID: 4133792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement fixation by rheumatoid factor.
    Tanimoto K; Cooper NR; Johnson JS; Vaughan JH
    J Clin Invest; 1975 Mar; 55(3):437-45. PubMed ID: 1078825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The detection of circulating immune complexes containing C1q and IgG using a new rapid serum ELISA test system.
    Reckel RP; Harris J; Botsko E; Wellerson R; Varga S
    Diagn Immunol; 1984; 2(4):228-37. PubMed ID: 6335421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class specific rheumatoid factors in rheumatoid arthritis: response to chrysotherapy and relationship to disease activity.
    Rudge SR; Pound JD; Bossingham DH; Powell RJ
    J Rheumatol; 1985 Jun; 12(3):432-6. PubMed ID: 3930719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgA and IgM rheumatoid factors in serum, saliva and other secretions: relationship to immunoglobulin ratios in systemic sicca syndrome and rheumatoid arthritis.
    Elkon KB; Gharavi AE; Patel BM; Hughes GR; Frankel A
    Clin Exp Immunol; 1983 Apr; 52(1):75-84. PubMed ID: 6861373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does IgA-alpha1 antitrypsin complex correlate with IgM, IgG and IgA rheumatoid factor in early rheumatoid arthritis?
    Lacki JK; Hrycaj P; Klama K; Mackiewicz U; Mackiewicz SH; Muller W
    Mater Med Pol; 1994; 26(3):97-100. PubMed ID: 7603085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor.
    Luthra HS; McDuffie FC; Hunder GG; Samayoa EA
    J Clin Invest; 1975 Aug; 56(2):458-66. PubMed ID: 125289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgM-RF prevents complement-mediated inhibition of immune precipitation.
    Mitchell WS; Naama JK; Veitch J; Whaley K
    Immunology; 1984 Jul; 52(3):445-8. PubMed ID: 6745994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in immunochemical characteristics of cryoglobulins in rheumatoid arthritis and systemic lupus erythematosus and their complement binding properties.
    Erhardt CC; Mumford P; Maini RN
    Ann Rheum Dis; 1984 Jun; 43(3):451-6. PubMed ID: 6611139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The stimulation of IgM rheumatoid factor from human B lymphocytes by rheumatoid arthritis complement-activating immune complexes.
    Lorber M; Samuel D; Amlot P; Panayi GS
    Clin Exp Immunol; 1988 Feb; 71(2):275-80. PubMed ID: 3258207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis.
    Newkirk MM; Goldbach-Mansky R; Senior BW; Klippel J; Schumacher HR; El-Gabalawy HS
    Rheumatology (Oxford); 2005 Nov; 44(11):1433-41. PubMed ID: 16091399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement mediated inhibition of immune precipitation in rheumatoid arthritis: studies on interaction of heat aggregated IgG with IgM rheumatoid factor.
    O'Sullivan MM; Amos N; Williams BD
    Ann Rheum Dis; 1988 Aug; 47(8):675-80. PubMed ID: 3261968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.